Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like John Rubino: Gold on “Epic Run” as Chaos... May 3, 2025 Collaboration with DuPont Water Solutions to Test Lithium... April 17, 2025 Editor’s Picks: Trump to Lift Minnesota Mining Ban,... June 14, 2025 Westport Announces Lock-Up Agreements in Support of the... May 1, 2025 DFS Investor Webinar Presentation July 2, 2025 John Feneck: Key Gold, Silver Price Levels, 10+... May 13, 2025 Ontario Tables Sweeping Bill to Restrict Foreign Access... May 3, 2025 Germany, Italy Face Pressure to Repatriate US$245 Billion... June 25, 2025 Brunswick Exploration June 19, 2025 Web3 Leaders Gather in Toronto for Canada Crypto... May 13, 2025
